CU20100162A7 - Asociación de un inhibidor de corriente sinusal if y de un beta-bloqueante - Google Patents

Asociación de un inhibidor de corriente sinusal if y de un beta-bloqueante

Info

Publication number
CU20100162A7
CU20100162A7 CU20100162A CU20100162A CU20100162A7 CU 20100162 A7 CU20100162 A7 CU 20100162A7 CU 20100162 A CU20100162 A CU 20100162A CU 20100162 A CU20100162 A CU 20100162A CU 20100162 A7 CU20100162 A7 CU 20100162A7
Authority
CU
Cuba
Prior art keywords
beta
association
sinusal
blocking
current inhibitor
Prior art date
Application number
CU20100162A
Other languages
English (en)
Other versions
CU24007B1 (es
Inventor
Guy Lerebours-Pigeonniere
Jean-Henri Calvet
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39666229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20100162(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of CU20100162A7 publication Critical patent/CU20100162A7/es
Publication of CU24007B1 publication Critical patent/CU24007B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Asociación de un inhibidor de corriente sinusal if y de un beta-bloqueante, así como las composiciones farmacéuticas que la contienen.
CU2010000162A 2008-02-14 2010-08-10 Asociación de un inhibidor de corriente sinusal if y de un beta-bloqueante CU24007B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800800A FR2927538B1 (fr) 2008-02-14 2008-02-14 Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
PCT/FR2009/000156 WO2009115669A1 (fr) 2008-02-14 2009-02-12 Association d'un inhibiteur du courant if sinusal et d'un bêta-bloquant

Publications (2)

Publication Number Publication Date
CU20100162A7 true CU20100162A7 (es) 2011-10-31
CU24007B1 CU24007B1 (es) 2014-06-27

Family

ID=39666229

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2010000162A CU24007B1 (es) 2008-02-14 2010-08-10 Asociación de un inhibidor de corriente sinusal if y de un beta-bloqueante

Country Status (37)

Country Link
US (1) US8217030B2 (es)
EP (2) EP2090303B1 (es)
JP (2) JP2009191069A (es)
KR (1) KR101078133B1 (es)
CN (1) CN101507726B (es)
AP (1) AP2010005366A0 (es)
AR (1) AR070416A1 (es)
AU (1) AU2009200393B2 (es)
BR (1) BRPI0900470A2 (es)
CA (1) CA2654210C (es)
CO (1) CO6290712A2 (es)
CR (1) CR11628A (es)
CU (1) CU24007B1 (es)
CY (1) CY1114113T1 (es)
DK (1) DK2090303T3 (es)
EA (1) EA200900137A1 (es)
EC (1) ECSP10010402A (es)
ES (1) ES2421893T3 (es)
FR (1) FR2927538B1 (es)
GE (1) GEP20115261B (es)
HN (1) HN2010001608A (es)
HR (1) HRP20130617T1 (es)
IL (1) IL207386A0 (es)
MA (1) MA31132B1 (es)
ME (1) ME01014B (es)
MX (1) MX2009001590A (es)
MY (1) MY149122A (es)
NI (1) NI201000139A (es)
NZ (1) NZ574843A (es)
PL (1) PL2090303T3 (es)
PT (1) PT2090303E (es)
RS (1) RS52834B (es)
SG (1) SG155130A1 (es)
SI (1) SI2090303T1 (es)
UA (1) UA99817C2 (es)
WO (1) WO2009115669A1 (es)
ZA (1) ZA200900894B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
US9674435B1 (en) * 2016-07-06 2017-06-06 Lawrence Maxwell Monari Virtual reality platforms for capturing content for virtual reality displays
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519925A1 (en) * 1989-11-21 1992-12-30 Sepracor, Inc. Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
WO2003024457A1 (en) * 2001-09-11 2003-03-27 Asahi Kasei Kabushiki Kaisha Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
ES2211846T3 (es) 2002-07-25 2004-07-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
CN101095682A (zh) * 2007-07-23 2008-01-02 北京本草天源药物研究院 一种伊伐布雷定或其药用盐的口服制剂

Also Published As

Publication number Publication date
US8217030B2 (en) 2012-07-10
CN101507726A (zh) 2009-08-19
JP2009191069A (ja) 2009-08-27
RS52834B (sr) 2013-10-31
EP2090303A1 (fr) 2009-08-19
UA99817C2 (ru) 2012-10-10
HRP20130617T1 (en) 2013-07-31
HK1137341A1 (en) 2010-07-30
IL207386A0 (en) 2010-12-30
EP2090303B1 (fr) 2013-05-01
WO2009115669A1 (fr) 2009-09-24
EP2409694A1 (fr) 2012-01-25
MX2009001590A (es) 2009-08-24
CU24007B1 (es) 2014-06-27
NI201000139A (es) 2011-01-10
AU2009200393B2 (en) 2013-11-07
NZ574843A (en) 2011-07-29
AU2009200393A1 (en) 2009-09-03
PT2090303E (pt) 2013-05-31
US20090209515A1 (en) 2009-08-20
ME01014B (me) 2012-10-20
SI2090303T1 (en) 2013-08-30
CA2654210C (fr) 2013-06-25
SG155130A1 (en) 2009-09-30
AR070416A1 (es) 2010-04-07
FR2927538A1 (fr) 2009-08-21
ES2421893T3 (es) 2013-09-06
KR101078133B1 (ko) 2011-10-28
HN2010001608A (es) 2013-10-07
JP2012211179A (ja) 2012-11-01
GEP20115261B (en) 2011-08-10
ECSP10010402A (es) 2010-09-30
CR11628A (es) 2010-11-22
FR2927538B1 (fr) 2010-02-19
ZA200900894B (en) 2009-12-30
CY1114113T1 (el) 2016-07-27
BRPI0900470A2 (pt) 2009-09-29
AP2010005366A0 (en) 2010-08-31
MY149122A (en) 2013-07-15
CO6290712A2 (es) 2011-06-20
DK2090303T3 (da) 2013-07-29
PL2090303T3 (pl) 2013-07-31
MA31132B1 (fr) 2010-02-01
KR20090088328A (ko) 2009-08-19
CN101507726B (zh) 2012-03-28
CA2654210A1 (fr) 2009-08-14
EA200900137A1 (ru) 2009-10-30

Similar Documents

Publication Publication Date Title
MX2019010602A (es) Inhibidores de cdk.
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
UY34536A (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos
SV2011003809A (es) Derivados de heteroarilo como inhibidores de dgat1
UY34216A (es) Nuevos compuestos que inhiben la actividad de la Lp-PLA2
HN2006000668A (es) Compuestos de quinolina heteroaromaticos
GT201300152A (es) Amidas aminoindanes con una alta actividad fungicida y sus composiciones fitosanitarias
CL2007002182S1 (es) Terminal.
UY3723Q (es) Aerosol
EA201170884A1 (ru) Производные пиперидина, пригодные в качестве антагонистов орексина
SV2010003631A (es) Aril pirrolinas insecticidas
UY31688A1 (es) Plaguicidas
PA8792401A1 (es) Fenilendiaminas
UY34818A (es) Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
UY34835A (es) ?Derivados de piperidina novedosos con actividad antagonista contra los receptores de procineticina?.
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
GT201300041A (es) Composicion fungicida sinergista
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
PA8667201A1 (es) Nuevos compuestos farmaceuticos
HN2009000856A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
BR112013028368A2 (pt) novos compostos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona e octahidropiridinona
EA201170585A1 (ru) Производные изохинолинона в качестве антагонистов nk3
CR20120343A (es) Moduladores de crth2

Legal Events

Date Code Title Description
FG Grant of patent